CSI Market
Sign In | Register

Bristol myers Squibb (BMY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BMY Annual Balance Sheets →
This page allows investors to track Bristol myers Squibb's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent8,722.00
Available-for-sale Securities, Debt Securities, Current MA2,345.00
Cash & Short-term Investments11,067.00
Accounts receivable10,553.00
Inventories2,737.00
Other current assets0.00
Prepaid Expense, Current AS3,296.00
Total Current Assets28,579.00
Equipment/Property/Plant Net13,340.00
Goodwill net21,740.00
Intangible Assets17,387.00
Long-term investments1,252.00
Insurance Recoverable332.00
Other Assets5,004.00
Deferred Income Tax Assets Net5,176.00
Total Assets87,634.00
Liabilities
Accounts Payable, Current AC4,158.00
Accrued Liabilities, Current AC881.00
Debt, Current LI1,027.00
Other current liabilities11,787.00
Accrued Income Taxes, Current TA806.00
Total Current Liabilities18,659.00
Long-term debt42,861.00
Other Long-term debt1,069.00
Total Long-term Debt43,930.00
Other Preferred stock150.00
Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent PE521.00
Accrued Income Taxes, Noncurrent AC1830.00
Other longterm liabilities1,225.00
Deferred Income Tax Liabilities Net211.00
Total Liabilities65,315.00
Stockholders' Equity
Treasury Stock Common Value-43,515.00
Common Stock Value292.00
Additional Paid In Capital Common Stock46,504.00
Retained Earnings / Accumulated Deficit20,316.00
Accumulated Other Comprehensive Income-1,290.00
Other Equity-1,290.00
Common Stockholder's Equity22,319.00
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.00
Total Stockholder's Equity22,319.00
Liabilities & Stockholder's Equity87,634.00
4 historic quarters locked

Sign in to unlock the full Bristol myers Squibb balance sheet history.

Sign In Create Free Account

About Bristol Myers Squibb Co Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 30, 2026
  • Source: bmy-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000014272-26-000020

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.